The Problem
-
Transgender and gender non-conforming adults are 9x more likely to attempt suicide. However, access to hormone treatments help and are the well-established standard of care.
-
Established gender-affirming standards of care are under legislative attack despite overwhelming evidence that they improve lives.
-
With no FDA approved medications for gender-affirming care, these treatments are extremely vulnerable to state law restrictions.
“I've experienced repeated discrimination and prejudices in the healthcare setting. I want my trans community to be able to access good healthcare from professionals who respect us."
– Leo Caldwell, transgender educator
Transgender and gender diverse communities, with a centuries-long history, are gaining global recognition and population growth. Gen Z stands as one of history's most diverse generations, with a remarkable 5% of US adults under 30 identifying as transgender or non-binary. Yet, this visibility has sparked a surge in opposition.
In recent years, anti-trans healthcare legislation has significantly increased, dimming progress in supporting these communities. In 2023, a record number of anti-trans healthcare bills have been introduced in US state legislatures.
It’s crucial to stress the paramount importance of protection against state bans. The transgender and gender diverse community urgently needs unwavering support, increased funding, and broader societal education and understanding. The lack of FDA approval for gender incongruence treatments exposes gender care to policy risks and discrimination. Standing with these communities is essential to ensure they receive the protection and resources they deserve.